Catalyst
Slingshot members are tracking this event:
Lilly (LLY) and Incyte (INCY) Announce Data from Phase 3 RA-BEGIN Study Demonstrating Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis Patients Treated With Baricitinib Compared with Adalimumab
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 07, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Adalimumab, Baricitinib, Humira, Rheumatoid Arthritis, Phase 3, Ra-begin
